Major step for implantable drug-delivery device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Download RSS feed: News Articles / In the Media / Audio
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Optimal size and shape allow implantable devices to last longer in the body.
MIT-Spain co-director describes how a La Caixa Fellowship impacted her research at MIT and led to the creation of the MIT-Spain Program.
Bhatia is recognized for her work in tissue engineering, disease detection, and advocacy for women in STEM.
Award to Professor Alex Shalek will support new advances in nanotechnology and chemical biology.
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Daniel Anderson wants to bring advances in drug delivery and biomaterials to the clinic.
Molecule stays in the bloodstream and is turned on when blood sugar levels are too high.
Study yields insight into generating antibodies that target different strains of HIV.
Liver cells derived from stem cells can be infected with malaria and used to test potential drugs.
Twelve new faces join six academic departments in the School of Engineering.